Formyl-Met-Leu-Phe induces calcium-dependent tyrosine phosphorylation of Rel-1 in neutrophils

Cell Calcium. 2003 Dec;34(6):445-55. doi: 10.1016/s0143-4160(03)00067-8.

Abstract

Chemoattractant priming and activation of PMNs results in changes in cytosolic Ca2+ concentration, tyrosine kinase activity, and gene expression. We hypothesize that the initial signaling for the activation of a 105kDa protein (Rel-1) requires Ca2+-dependent tyrosine phosphorylation. A rapid and time-dependent tyrosine phosphorylation of Rel-1 occurred following formyl-Met-Leu-Phe (fMLP) stimulation of human PMNs at concentrations that primed or activated the NADPH oxidase (10(-9) to 10(-6)M), becoming maximal after 30s. Pretreatment with pertussis toxin (Ptx) or tyrosine kinase inhibitors abrogated this phosphorylation and inhibited fMLP activation of the oxidase. The fMLP concentrations employed also caused a rapid increase in cytosolic Ca2+ but chelation negated the effects, including the cytosolic Ca2+ flux, oxidase activation, and the tyrosine phosphorylation of Rel-1. Conversely, chelation of extracellular Ca2+ decreased the fMLP-mediated Ca2+ flux, had no affect on the oxidase, and augmented tyrosine phosphorylation of Rel-1. Phosphorylation of Rel-1 was inhibited when PMNs were preincubated with a p38 MAP kinase (MAPK) inhibitor (SB203580). In addition, fMLP elicited rapid activation of p38 MAPK which was abrogated by chelation of cytosolic Ca2+. Thus, fMLP concentrations that prime or activate the oxidase cause a rapid Ca2+-dependent tyrosine phosphorylation of Rel-1 involving p38 MAPK activation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Calcium / metabolism*
  • Cytosol
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Gene Expression
  • Humans
  • I-kappa B Proteins / metabolism
  • Imidazoles / pharmacology
  • Mitogen-Activated Protein Kinases / drug effects
  • Mitogen-Activated Protein Kinases / metabolism
  • Molecular Weight
  • N-Formylmethionine Leucyl-Phenylalanine / antagonists & inhibitors
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology*
  • NADPH Oxidases / drug effects
  • NADPH Oxidases / metabolism
  • NF-kappa B / metabolism
  • Neutrophils / drug effects
  • Neutrophils / metabolism*
  • Pertussis Toxin / pharmacology
  • Phosphorylation / drug effects
  • Protein-Tyrosine Kinases / metabolism
  • Protein-Tyrosine Kinases / pharmacology
  • Pyridines / pharmacology
  • Transcription Factors / genetics
  • Transcription Factors / metabolism*
  • Tyrosine / metabolism*
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Enzyme Inhibitors
  • I-kappa B Proteins
  • Imidazoles
  • NF-kappa B
  • Pyridines
  • Transcription Factors
  • Tyrosine
  • N-Formylmethionine Leucyl-Phenylalanine
  • NADPH Oxidases
  • Pertussis Toxin
  • Protein-Tyrosine Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580
  • Calcium